289 related articles for article (PubMed ID: 11158615)
1. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1.
Asher G; Lotem J; Cohen B; Sachs L; Shaul Y
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1188-93. PubMed ID: 11158615
[TBL] [Abstract][Full Text] [Related]
2. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
[TBL] [Abstract][Full Text] [Related]
3. NQO1 stabilizes p53 through a distinct pathway.
Asher G; Lotem J; Kama R; Sachs L; Shaul Y
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3099-104. PubMed ID: 11867746
[TBL] [Abstract][Full Text] [Related]
4. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1.
Asher G; Lotem J; Tsvetkov P; Reiss V; Sachs L; Shaul Y
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15065-70. PubMed ID: 14634213
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.
Pink JJ; Planchon SM; Tagliarino C; Varnes ME; Siegel D; Boothman DA
J Biol Chem; 2000 Feb; 275(8):5416-24. PubMed ID: 10681517
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.
Tsvetkov P; Asher G; Reiss V; Shaul Y; Sachs L; Lotem J
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5535-40. PubMed ID: 15809436
[TBL] [Abstract][Full Text] [Related]
7. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.
Gong X; Kole L; Iskander K; Jaiswal AK
Cancer Res; 2007 Jun; 67(11):5380-8. PubMed ID: 17545619
[TBL] [Abstract][Full Text] [Related]
8. Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner.
Park EJ; Min KJ; Choi KS; Kwon TK
Exp Cell Res; 2014 Apr; 323(1):144-154. PubMed ID: 24462458
[TBL] [Abstract][Full Text] [Related]
9. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V
World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521
[TBL] [Abstract][Full Text] [Related]
10. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.
Watanabe J; Nishiyama H; Matsui Y; Ito M; Kawanishi H; Kamoto T; Ogawa O
Oncogene; 2006 Apr; 25(17):2500-8. PubMed ID: 16518417
[TBL] [Abstract][Full Text] [Related]
11. Dicoumarol inhibits rat NAD(P)H:quinone oxidoreductase in vitro and induces its expression in vivo.
Stiborova M; Levova K; Barta F; Dracinska H; Sulc M; Hodek P; Frei E; Arlt VM; Schmeiser HH
Neuro Endocrinol Lett; 2014; 35 Suppl 2():123-32. PubMed ID: 25638376
[TBL] [Abstract][Full Text] [Related]
12. beta-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3.
Planchon SM; Pink JJ; Tagliarino C; Bornmann WG; Varnes ME; Boothman DA
Exp Cell Res; 2001 Jul; 267(1):95-106. PubMed ID: 11412042
[TBL] [Abstract][Full Text] [Related]
13. β-Lapachone Induces Acute Oxidative Stress in Rat Primary Astrocyte Cultures that is Terminated by the NQO1-Inhibitor Dicoumarol.
Steinmeier J; Kube S; Karger G; Ehrke E; Dringen R
Neurochem Res; 2020 Oct; 45(10):2442-2455. PubMed ID: 32789798
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure/activity relationships and functional activity in tumour cells.
Nolan KA; Scott KA; Barnes J; Doncaster J; Whitehead RC; Stratford IJ
Biochem Pharmacol; 2010 Oct; 80(7):977-81. PubMed ID: 20599803
[TBL] [Abstract][Full Text] [Related]
15. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1.
Asher G; Bercovich Z; Tsvetkov P; Shaul Y; Kahana C
Mol Cell; 2005 Mar; 17(5):645-55. PubMed ID: 15749015
[TBL] [Abstract][Full Text] [Related]
16. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
[TBL] [Abstract][Full Text] [Related]
17. Can dicoumarol be used as a gonad-safe anticancer agent: an in vitro and in vivo experimental study.
Aras D; Cinar O; Cakar Z; Ozkavukcu S; Can A
Mol Hum Reprod; 2016 Jan; 22(1):57-67. PubMed ID: 26612783
[TBL] [Abstract][Full Text] [Related]
18. Quinone reductase inhibitors block SAPK/JNK and NFkappaB pathways and potentiate apoptosis.
Cross JV; Deak JC; Rich EA; Qian Y; Lewis M; Parrott LA; Mochida K; Gustafson D; Vande Pol S; Templeton DJ
J Biol Chem; 1999 Oct; 274(44):31150-4. PubMed ID: 10531305
[TBL] [Abstract][Full Text] [Related]
19. Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1).
Megarity CF; Abdel-Aal Bettley H; Caraher MC; Scott KA; Whitehead RC; Jowitt TA; Gutierrez A; Bryce RA; Nolan KA; Stratford IJ; Timson DJ
Chembiochem; 2019 Nov; 20(22):2841-2849. PubMed ID: 31165578
[TBL] [Abstract][Full Text] [Related]
20. Quinone reductases multitasking in the metabolic world.
Ross D
Drug Metab Rev; 2004 Oct; 36(3-4):639-54. PubMed ID: 15554240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
